Many important advances in recent years have brought new therapies to people with MS, but much work remains to fully cure the disease. In the past, researchers have faced an enormous challenge as they tried to develop and execute fruitful experimental strategies: no centralized place fostered the generation and exchange of novel ideas about the causes, mechanisms, and potential cures for MS.
ACP, the MassGeneral Institute for Neurodegenerative Disease (MIND), and the Max Planck Institute for Molecular Genetics sought to address that gap by creating the Multiple Sclerosis Discovery Forum (MSDF)—the first information portal and interactive, virtual community that educates and connects investigators who study MS and other demyelinating disorders of the central nervous system, including transverse myelitis, neuromyelitis optica, and acute disseminated encephalomyelitis.
In a single website, MSDF brings together original and insightful journalistic content about MS research findings, opportunities for researchers to discuss and debate the implications of these findings, resource listings to help connect scientists with the things they need, and much more. By consolidating these tools and opportunities in a central location, MSDF aims to help MS researchers achieve faster progress more efficiently.
ACP is extremely grateful to founding donor EMD Serono for providing the funding necessary to build and launch MSDF.